Reglagene

www.reglagene.com

Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better therapies that improve quality of life and extend life. The Reglagene team is developing a first-in-class blood–brain barrier (BBB) penetrant medicine that effectively fights brain cancer.

Read more

Reach decision makers at Reglagene

Lusha Magic

Free credit every month!

Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better therapies that improve quality of life and extend life. The Reglagene team is developing a first-in-class blood–brain barrier (BBB) penetrant medicine that effectively fights brain cancer.

Read more
icon

Country

icon

State

Arizona

icon

City (Headquarters)

Tucson

icon

Employees

1-10

icon

Founded

2016

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Vice President of Pre - Clinical Biology

    Email ****** @****.com
    Phone (***) ****-****
  • Vice President of Discovery

    Email ****** @****.com
    Phone (***) ****-****
  • Board Member | Oncology and Cns | Rare Disease

    Email ****** @****.com
    Phone (***) ****-****
  • Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(17)

Reach decision makers at Reglagene

Free credits every month!

My account

Sign up now to uncover all the contact details